z-logo
Premium
Programmable RNA N 1 ‐Methyladenosine Demethylation by a Cas13d‐Directed Demethylase
Author(s) -
Xie Shanshan,
Jin Hao,
Yang Feng,
Zheng Hong,
Chang Yongxia,
Liao Ying,
Zhang Ye,
Zhou Tianhua,
Li Yang
Publication year - 2021
Publication title -
angewandte chemie international edition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.831
H-Index - 550
eISSN - 1521-3773
pISSN - 1433-7851
DOI - 10.1002/anie.202105253
Subject(s) - demethylase , demethylation , n6 methyladenosine , chemistry , biochemistry , methyltransferase , methylation , dna , epigenetics , dna methylation , gene , gene expression
N 1 ‐methyladenosine (m 1 A) is a prevalent and reversible RNA modification, which plays a crucial role in the regulation of RNA fate and gene expression. However, the lack of tools to precisely manipulate m 1 A sites in specific transcripts has hindered efforts to clarify the association between a specific m 1 A‐modified transcript and its phenotypic outcomes. Here we develop a CRISPR‐Cas13d‐based tool called re engineered m 1 A mo dification v alid er aser (termed “REMOVER”) for targeted m 1 A demethylation of a specific transcript. The catalytically inactive RfxCas13d (dCasRx) is fused to the m 1 A demethylase ALKBH3, and the dCasRx‐ALKBH3 fusion protein can mediate potent demethylation of m 1 A‐modified RNAs. We further find that REMOVER can specifically demethylate m 1 A of MALAT1 and PRUNE1 RNAs, thereby significantly increasing their stability. Our study establishes REMOVER as a tool for targeted RNA demethylation of specific m 1 A‐modified transcripts, which enables further elucidation of the relationship between m 1 A modification of specific transcripts and their phenotypic outcomes.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom